Despite their advantages, 3D tumor models come with certain challenges:
1. Complexity and Cost: Creating and maintaining 3D tumor models can be more complex and expensive compared to 2D cultures. 2. Standardization: There is a lack of standardized protocols, which can lead to variability in results. 3. Scalability: Scaling up these models for high-throughput drug screening remains a challenge.
